EUVIMEDAtrasti EUVIMED
Open access

Piwei Peiyuan Pill Ameliorates Chronic Atrophic Gastritis and Intestinal Metaplasia at Least in Part by Inhibiting the Pellino1/IRAK1/NF‐κB Signaling Axis

Cheng Zhang, Fei Lu iD, Ting Ye, Yueping Jin, Yunpeng Qin iD, Kairui Wu, Kai Liu, Xuncui Wang, Hang Song iD, Xuejun Li iD

Cell Biology International · 2026-08 · 50 (8)

DOI: 10.1002/cbin.70195 ↗

At a glance

Journal article in Cell Biology International, published online on 2026-08-12. Written by Cheng Zhang and 9 co-authors. Institution: The Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China. Major MEDLINE topics: Gastritis, Atrophic, NF-kappa B, Drugs, Chinese Herbal, Interleukin-1 Receptor-Associated Kinases. 61 references. The full text is freely available in PubMed Central. Funded by: National Natural Science Foundation of China, Anhui Provincial Health Research Project, Anhui Provincial University Scientific Research Program Project.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Chronic atrophic gastritis (CAG) with intestinal metaplasia (IM) is a key precancerous lesion that may progress to intestinal‐type gastric adenocarcinoma. Piwei Peiyuan Pill (PPP) has shown significant clinical efficacy in ameliorating CAG with IM, but its active components and underlying mechanisms remain unclear. High‐performance liquid chromatography (HPLC) and ultra‐high performance liquid chromatography coupled with high‐resolution mass spectrometry (UHPLC‐HRMS) were used to identify the components of PPP and the active ingredients in PPP‐containing serum. The therapeutic efficacy and potential mechanisms of PPP were further investigated via transcriptomic sequencing and experimental validation. UHPLC‐HRMS analysis of PPP‐containing serum identified several bioactive components, including esculin, lithospermic acid, and atractylenolide III. In CAG rats, PPP significantly ameliorated gastric mucosal damage and reduced serum IL‐6 and TNF‐α levels. Transcriptomic results showed that IRAK1 was highly expressed in CAG patients with IM and associated with activation of the NF‐κB pathway. PPP intervention dose‐dependently suppressed hyperactivation of the Pellino1/IRAK1/NF‐κB axis and decreased the expression of intestinal metaplasia markers CDX1 and MUC2. Additionally, PPP improved immune function by increasing the proportion of CD4 + T cells and decreasing the proportion of CD8 + T cells in CAG model rats. Taken together, these findings suggest that PPP mitigates CAG and attenuates IM at least in part by suppressing the Pellino1/IRAK1/NF‐κB signaling pathway, indicating that it may serve as a promising therapeutic strategy for reducing inflammation‐associated gastric carcinogenesis.

Subjects

MeSH terms (MEDLINE)

Gastritis, AtrophicNF-kappa BDrugs, Chinese HerbalInterleukin-1 Receptor-Associated KinasesAnimalsMetaplasiaSignal TransductionMaleRatsHumansRats, Sprague-DawleyUbiquitin-Protein LigasesGastric MucosaChronic Disease

Author keywords

IRAK1chronic atrophic gastritisinflammationintestinal metaplasia

Substances

NF-kappa BDrugs, Chinese HerbalInterleukin-1 Receptor-Associated KinasesUbiquitin-Protein Ligases

Authors and institutions

  • The Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China.
  • Anhui University of Chinese Medicine, Hefei, Anhui, China.
  • Department of Pharmacology, Zhangjiajie College, Zhangjiajie, Hunan, China.
  • School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, Anhui, China.
  • Functional Activity and Resource Utilization of Edible and Medicinal Fungi Anhui Provincial Joint Key Laboratory, Anhui University of Chinese Medicine, Hefei, Anhui, China.
  • Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu, Anhui, China.

ORCID profiles: Fei Lu, Yunpeng Qin, Hang Song, Xuejun Li

Funding

  • National Natural Science Foundation of China
  • Anhui Provincial Health Research Project
  • Anhui Provincial University Scientific Research Program Project

Cite

APA

Zhang, C., Lu, F., Ye, T., Jin, Y., Qin, Y., Wu, K., Liu, K., Wang, X., Song, H., & Li, X. (2026). Piwei Peiyuan Pill Ameliorates Chronic Atrophic Gastritis and Intestinal Metaplasia at Least in Part by Inhibiting the Pellino1/IRAK1/NF‐κB Signaling Axis. Cell Biology International, 50(8). https://doi.org/10.1002/cbin.70195

Vancouver

Zhang C, Lu F, Ye T, Jin Y, Qin Y, Wu K, et al. Piwei Peiyuan Pill Ameliorates Chronic Atrophic Gastritis and Intestinal Metaplasia at Least in Part by Inhibiting the Pellino1/IRAK1/NF‐κB Signaling Axis. Cell Biology International. 2026;50(8). doi:10.1002/cbin.70195

BibTeX
@article{Zhang2026,
  author = {Zhang, Cheng and Lu, Fei and Ye, Ting and Jin, Yueping and Qin, Yunpeng and Wu, Kairui and Liu, Kai and Wang, Xuncui and Song, Hang and Li, Xuejun},
  title = {Piwei Peiyuan Pill Ameliorates Chronic Atrophic Gastritis and Intestinal Metaplasia at Least in Part by Inhibiting the Pellino1/IRAK1/NF‐κB Signaling Axis},
  journal = {Cell Biology International},
  year = {2026},
  volume = {50},
  number = {8},
  doi = {10.1002/cbin.70195}
}
Start for free →